期刊文献+

马归液膀胱灌注治疗腺性膀胱炎的临床疗效分析 被引量:8

Clinical Effect of Magui Liquild for Bladder Instillation on Cystitis Glandularis
暂未订购
导出
摘要 目的研究马归液膀胱灌注治疗腺性膀胱炎的疗效及安全性。方法选取我院2012年1月至2015年7月间符合纳入标准的患者61例,将选入的患者随机分为马归液组39例和吡柔比星组22例,其中马归液组予以自制中药马归液进行膀胱灌注治疗,吡柔比星组予以吡柔比星进行膀胱灌注治疗。结果经治疗后,马归液组的治疗有效率高于吡柔比星组,且有统计学意义(P<0.05);两组治疗前与治疗后各组最大尿流率、平均尿流率的比较均有统计学意义(P<0.05),两组间比较,最大尿流率差异无统计学意义(P>0.05)、平均尿流率差异有统计学意义(P<0.05)。结论采用马归液膀胱灌注治疗腺性膀胱炎具有确切疗效。 Objective To study the efficacy and safety of the treatment of bladder instillation with Magui Liquid in the treatment of cystitis. Methods The 61 cases of patients met the inclusion criteria in our hospital from January 2012 to July2015 were randomly divided into Magui Liquid group(39 cases) and perarubicin group(22 cases). The Magui Liquid group was given bladder perfusion for Magui Liguid, and the perarubicin group was bladder perfusion for perarubicin. Results After treatment, the effective rate of Magui Liguid group was higher than the perarubicin group, with statistical significance(P〈0.05).The maximum urinary flow rate and average urinary flow rate of the two groups before and after treatment were statistically significant(P〈0.05). The maximum urinary flow rate between the two groups was not statistically significant(P〉0.05), while average urinary flow rate was statistically significant(P〈0.05). Conclusion The Magui Liquid by bladder instillation shows good effect on cystitis glandularis.
出处 《湖南中医药大学学报》 CAS 2016年第10期60-63,共4页 Journal of Hunan University of Chinese Medicine
基金 湖南省自然科学基金项目(13JJ5029) 湖南省教育厅优秀青年项目(15B175)
关键词 腺性膀胱炎 马归液 膀胱灌注 cystitis glandularis Magui Liquid bladder irrigation
  • 相关文献

参考文献8

二级参考文献83

  • 1陈志强,位志峰,叶章群,杨为民.腺性膀胱炎中肿瘤相关指标的改变和临床分型的探讨[J].中华医学杂志,2005,85(26):1842-1844. 被引量:35
  • 2李秀银,张平,赵淑香.膀胱镜对腺性膀胱炎的诊断价值(附11例误诊分析)[J].河南外科学杂志,2007,13(2):12-13. 被引量:2
  • 3佟咸利,张连成,刘屹立,宫大鑫,王平.腺性膀胱炎组织中MAPK信号传导作用的相关研究[J].中国医科大学学报,2007,36(1):71-72. 被引量:10
  • 4王卫东,陈正堂.Bcl-2/Bax比率与细胞“命运”[J].中国肿瘤生物治疗杂志,2007,14(4):393-396. 被引量:165
  • 5Sarela AI, Scott N, Ramsdale J, et al. Immunohistochemical detection of the anti-apoptosis protein, survivin, predicts survival after curative resection of stage II colorectal carci- nomas[J]. Ann Surg Oncol, 2001, 8(4):305-310.
  • 6Sarela AI, Macadam RC. Expression of the antiapoptasis gene, surviving, predicts death from recurrent colorectal car- cinoma[J]. Gut, 2000, 46(5):645-650.
  • 7Cho S, Lee JH, Cho SB, et al. Epigenetic methylation and ex- pression of caspase 8 and surviving in hepatocellular carci- noma [J]. Pathol Int, 2010, 60(3):203-21 I.
  • 8Bayram S, Akkiz H, Bekar A, et al. The association between the surviving-31 G/C promoter polymorphism and hepatocel- lular carcinoma risk in a Turkish population[J]. Cancer Epi-demiol, 2011, 35(6):555-559.
  • 9Li F. Role of Survivin and its splice variants in tumorigenesis [J]. Br J Cancer, 2005, 92(2):212-216.
  • 10McNeish IA, Lopes R, Bell S J, et al. Survivin interacts with Smac/DIABLO in ovarian carcinoma cells but is redundant in Smac mediated apoptosis[J]. Exp Cell Res, 2005, 302(1):69-82.

共引文献34

同被引文献79

引证文献8

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部